Peter Huebener
Overview
Explore the profile of Peter Huebener including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
1522
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Foelsch K, Pelczar P, Zierz E, Kondratowicz S, Qi M, Mueller C, et al.
J Crohns Colitis
. 2024 Jan;
18(7):1122-1133.
PMID: 38285546
Background: High-mobility group box protein 1 [HMGB1] is a ubiquitous nucleoprotein with immune-regulatory properties following cellular secretion or release in sterile and in infectious inflammation. Stool and serum HMGB1 levels...
2.
Pischke S, Ashouri M, Peters U, Shiprov A, Schulze Zur Wiesch J, Sterneck M, et al.
World J Hepatol
. 2024 Jan;
15(12):1325-1332.
PMID: 38223419
Background: Periodontitis has been associated with various liver diseases. However, the relevance of periodontitis in the progression of decompensated cirrhosis remains inconclusive. In particular, it is unclear whether the common...
3.
Huebener P, Amin T, Lohse A
Visc Med
. 2024 Jan;
39(6):163-165.
PMID: 38205273
No abstract available.
4.
Vogel M, Ehlken H, Kluge S, Roesch T, Lohse A, Huber S, et al.
Eur J Intern Med
. 2022 Jun;
102:54-62.
PMID: 35672219
Background & Aims: Acute pancreatitis (AP) is a frequent indication for hospitalization and may present with varying degrees of severity. AP often coincides with hepatic disease, yet the impact of...
5.
Mederacke I, Filliol A, Affo S, Nair A, Hernandez C, Sun Q, et al.
Sci Transl Med
. 2022 Apr;
14(639):eabe5795.
PMID: 35385339
Fibrosis contributes to ~45% of deaths in western countries. In chronic liver disease, fibrosis is a major factor determining outcomes, but efficient antifibrotic therapies are lacking. Although platelet-derived growth factor...
6.
Volmari A, Foelsch K, Zierz E, Yan K, Qi M, Bartels K, et al.
Hepatol Commun
. 2021 Sep;
5(12):2104-2120.
PMID: 34558858
High-mobility group box 1 (HMGB1) is a nucleoprotein with proinflammatory functions following cellular release during tissue damage. Moreover, antibody-mediated HMGB1 neutralization alleviates lipopolysaccharide (LPS)-induced shock, suggesting a role for HMGB1...
7.
Goosmann L, Buchholz A, Bangert K, Fuhrmann V, Kluge S, Lohse A, et al.
Liver Int
. 2021 Sep;
41(3):574-584.
PMID: 34542228
Background: Among patients with cirrhosis, candidate selection and timing of liver transplantation (LT) remain problematic. Acute-on-chronic liver failure (ACLF) is a severe complication of cirrhosis with excessive short-term mortality rates...
8.
Hoste E, Maueroder C, Van Hove L, Catrysse L, Vikkula H, Sze M, et al.
Cell Rep
. 2019 Nov;
29(9):2689-2701.e4.
PMID: 31775038
Regenerative responses predispose tissues to tumor formation by largely unknown mechanisms. High-mobility group box 1 (HMGB1) is a danger-associated molecular pattern contributing to inflammatory pathologies. We show that HMGB1 derived...
9.
Hernandez C, Huebener P, Pradere J, Antoine D, Friedman R, Schwabe R
J Clin Invest
. 2019 Apr;
129(4):1803.
PMID: 30932913
No abstract available.
10.
Hernandez C, Huebener P, Pradere J, Antoine D, Friedman R, Schwabe R
J Clin Invest
. 2019 Apr;
129(4):1803.
PMID: 30932911
No abstract available.